Show Summary Details
Page of

Contraceptive implants 

Contraceptive implants
Chapter:
Contraceptive implants
Author(s):

Enda McVeigh

, John Guillebaud

, and Roy Homburg

DOI:
10.1093/med/9780199650682.003.0026
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 April 2021

Introduction

Mechanism of action, administration, and effectiveness

Enzyme inducer drug (EID) treatment

Indications

Advantages

Disadvantages and contraindications

Counselling and ongoing supervision

Reversibility and removal problems

Implants contain a progestogen in a slow-release carrier, made either of dimethylsiloxane (as in JadelleTM not available in UK) with two implants, or of ethylene vinyl acetate (EVA) as Nexplanon...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.